In the present study, genetic diversity and mycotoxin profiles of Aspergillus flavus isolated from air (indoors and outdoors), levels (surfaces), and soils of five hospitals in Southwest Iran were examined. From a total of 146 Aspergillus colonies, 63 isolates were finally identified as A. flavus by a combination of colony morphology, microscopic criteria, and mycotoxin profiles. No Aspergillus parasiticus was isolated from examined samples. Chromatographic analyses of A. flavus isolates cultured on yeast extract-sucrose broth by tip culture method showed that approximately 10% and 45% of the isolates were able to produce aflatoxin B(1) (AFB(1)) and cyclopiazonic acid (CPA), respectively. Around 40% of the isolates produced sclerotia on Czapek-Dox agar. The isolates were classified into four chemotypes based on the ability to produce AF and CPA that majority of them (55.5%) belonged to chemotype IV comprising non-mycotoxigenic isolates. Random amplified polymorphic DNA (RAPD) profiles generated by a combination of four selected primers were used to assess genetic relatedness of 16 selected toxigenic and non-toxigenic isolates. The resulting dendrogram demonstrated the formation of two separate clusters for the A. flavus comprised both mycotoxigenic and non-toxigenic isolates in a random distribution. The obtained results in this study showed that RAPD profiling is a promising and efficient tool to determine intra-specific genetic variation among A. flavus populations from hospital environments. A. flavus isolates, either toxigenic or non-toxigenic, should be considered as potential threats for hospitalized patients due to their obvious role in the etiology of nosocomial aspergillosis.

Department of Mycology Faculty of Medical Sciences Tarbiat Modares University Tehran 14115 331 Iran

Zobrazit více v PubMed

Clin Microbiol Infect. 2003 Dec;9(12):1191-202 PubMed

Clin Microbiol Infect. 2001;7 Suppl 2:38-45 PubMed

Folia Biol (Praha). 1999;45(3):97-9 PubMed

Mycopathologia. 2006 Mar;161(3):183-92 PubMed

Appl Environ Microbiol. 1999 Apr;65(4):1444-9 PubMed

Toxicol Ind Health. 2009 Oct-Nov;25(9-10):657-67 PubMed

Mycopathologia. 2009 Nov;168(5):257-68 PubMed

Int J Food Microbiol. 2007 Feb 15;113(3):330-8 PubMed

Appl Environ Microbiol. 1996 Aug;62(8):2947-52 PubMed

J Hosp Infect. 2006 Jul;63(3):246-54 PubMed

Mem Inst Oswaldo Cruz. 2007 Sep;102(6):687-92 PubMed

J Hosp Infect. 2002 Nov;52(3):185-91 PubMed

Diagn Microbiol Infect Dis. 1999 Jul;34(3):221-7 PubMed

Biosci Biotechnol Biochem. 2007 Sep;71(9):2329-32 PubMed

J Gen Microbiol. 1963 Sep;32:397-402 PubMed

J Hosp Infect. 2004 Sep;58(1):59-62 PubMed

Am J Infect Control. 2009 Apr;37(3):189-94 PubMed

Appl Environ Microbiol. 1999 May;65(5):2264-6 PubMed

Mycopathologia. 2002;153(1):41-8 PubMed

Sci Total Environ. 2010 Sep 15;408(20):4285-95 PubMed

J Clin Microbiol. 2001 Sep;39(9):3360-1 PubMed

Mycologia. 2005 Mar-Apr;97(2):425-32 PubMed

Appl Environ Microbiol. 1983 Dec;46(6):1435-7 PubMed

Genet Mol Res. 2008 Aug 05;7(3):706-17 PubMed

Appl Environ Microbiol. 1988 Aug;54(8):2096-100 PubMed

Rev Iberoam Micol. 2001 Dec;18(4):156-62 PubMed

Fungal Genet Biol. 2003 Jul;39(2):103-17 PubMed

J Clin Microbiol. 1998 Jun;36(6):1494-500 PubMed

An insight into the distribution, genetic diversity, and mycotoxin production of Aspergillus section Flavi in soils of pistachio orchards